Abstract

BackgroundInfective endocarditis (IE) is commonly complicated by cerebral embolization and hemorrhage secondary to intracranial mycotic aneurysms (ICMAs). These complications are associated with poor outcome and may require diagnostic and therapeutic plans to be modified. However, routine screening by brain CT and CT angiography (CTA) is not standard practice. We aimed to study the impact of routine cerebral CTA on treatment decisions for patients with IE.MethodsFrom July 2007 to December 2012, we prospectively recruited 81 consecutive patients with definite left-sided IE according to modified Duke’s criteria. All patients had routine brain CTA conducted within one week of admission. All patients with ICMA underwent four-vessel conventional angiography. Invasive treatment was performed for ruptured aneurysms, aneurysms ≥5 mm, and persistent aneurysms despite appropriate therapy. Surgical clipping was performed for leaking aneurysms if not amenable to intervention. Results: The mean age was 30.43±8.8 years and 60.5% were males. Staph aureus was the most common organism (32.3%). Among the patients, 37% had underlying rheumatic heart disease, 26% had prosthetic valves, 23.5% developed IE on top of a structurally normal heart and 8.6% had underlying congenital heart disease. Brain CT/CTA revealed that 51 patients had evidence of cerebral embolization, of them 17 were clinically silent. Twenty-six patients (32%) had ICMA, of whom 15 were clinically silent. Among the patients with ICMAs, 11 underwent endovascular treatment and 2 underwent neurovascular surgery. The brain CTA findings prompted different treatment choices in 21 patients (25.6%). The choices were aneurysm treatment before cardiac surgery rather than at follow-up, valve replacement by biological valve instead of mechanical valve, and withholding anticoagulation in patients with prosthetic valve endocarditis for fear of aneurysm rupture.ConclusionsRoutine brain CT/CTA resulted in changes in the treatment plan in a significant proportion of patients with IE, even those without clinically evident neurological disease. Routine brain CT/CTA may be indicated in all hospitalized patients with IE.

Highlights

  • Despite the advances in diagnostic and therapeutic techniques, infective endocarditis (IE) remains a challenging disease with high rates of morbidity

  • We aimed to study the impact of routine cerebral CT angiography (CTA) on treatment decisions for patients with IE

  • Routine brain CT/CTA resulted in changes in the treatment plan in a significant proportion of patients with IE, even those without clinically evident neurological disease

Read more

Summary

Introduction

Despite the advances in diagnostic and therapeutic techniques, infective endocarditis (IE) remains a challenging disease with high rates of morbidity. Neurological complications in IE are strong predictors of mortality [2,3]; the overall mortality among IE patients with ICMAs is 60% and may reach 80% with ruptured ICMAs[4,5] Autopsy and clinical studies have shown that a significant proportion of cerebral embolizations are clinically silent.[6] Most ICMAs remain silent and rupture suddenly with catastrophic consequences even after apparent bacteriological cure.[7,8] Subclinical infarcts, cerebral hemorrhage and ICMA can complicate the course of treatment and alter treatment decisions, in patients who require cardiac surgery and valve replacement Despite their high incidence and the dismal prognosis, routine screening for neurological complications is not standard practice in IE.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call